PharmaShots | Incisive News in 3 Shots

Subscribe Now

germline brca-mutated metastatic pancreatic cancer

AstraZeneca and Merck & Co Receive the US FDA Advisory Committee's Recommendation on Approval of Lynparza (olaparib) as 1L Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancr

AstraZeneca and Merck & Co Receive the US FDA Advisory Committee's Recommendation on Approval of Lynparza (olaparib) as 1L Mai...

December 18, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us